GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of the half-life thing finally clicked for me and I want to write it down — 40 comments in the full submission. View in context.
1.9k
c/glp1science·submitted 2 years ago by u/hassan_ostergaard

the half-life thing finally clicked for me and I want to write it down

Questionbranch of 6 comments

the half-life thing finally clicked for me and I want to write it down. Not a hot take, just something I have not seen said plainly here. Started reading limitations sections first. It has changed how much weight I give to almost everything posted here. The half-life explanation was the thing that made weekly dosing…

Read the full submission and all 40 comments →

This branch

6 comments, started 2 years ago
u/aleksi_lehtinen175 points·2 years ago

I would not read that in vitro number across to a person. The conditions are nothing like physiological.

replysharereportpermalink
[removed]132 points·2 years ago

[removed by moderator]

replysharereportpermalink
u/neha_krastev0 points·2 years ago

That study was in a rodent model. Worth stating, since the thread has been reading it as human data.

replysharereportpermalink
u/gradient_goblin102 points·2 years ago

albumin binding is most of the half-life story

replysharereportpermalink
u/ismael_eriksen0 points·2 years ago

I would not read that in vitro number across to a person.

This is the concept everything else on this board is downstream of.

replysharereportpermalink
u/rina_bergstrom143 points·2 years ago

Small fix — it slows gastric emptying, it does not halt it, and the distinction matters for the mechanism you are proposing.

replysharereportpermalink

← back to the whole thread

About c/glp1science

The mechanism layer: incretin physiology, receptor distribution, gastric emptying, central appetite signalling, glucagon-receptor contribution, amylin co-agonism, and the pharmacokinetics that make weekly dosing possible. Papers get cited by journal and year or they get a [needs source] reply.

50kmembers
95submissions
Oct 2023created
submissions / month, last year
Sponsored

Janoshik Analytical

Independent HPLC and mass spec. The number you get is the number they found.

janoshik.com
Sponsored

GL Biochem (Shanghai)

Custom peptides and amino acids direct from the manufacturer since 1998. ISO 9001 / cGMP. Batch COA every order.

glbiochem.net
c/glp1science rules
  1. Cite the paper: journal, year, first author. Links optional, citation mandatory.
  2. Mechanistic speculation is welcome if flaired as speculation.
  3. No extrapolating rodent data to human dosing without saying that is what you are doing.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.